Quanterix LOGO.jpg
SIMOA HD-1 ANALYZER

Quanterix are on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. Click on one of the therapeutic category icons below to learn how our revolutionary technology is helping researchers advance the science of precision health.

icon01.png
icon02.png
icon03.png
icon04.png
icon05 copy.png

DELIVERING ULTRASENSITIVE BIOMARKER MEASUREMENT YOU CAN COUNT ON.

Quanterix is re-engineering ultrasensitivity with the launch of the Simoa HD-X Analyzer™, the latest model fully
automated Simoa bead-based immunoassay platform. Leveraging years of experience with the ground-breaking
Simoa HD-1 Analyzer, the new flagship HD-X delivers major productivity improvements, greater user flexibility,
unparalleled sensitivity, and best-in-class assay performance across a broad assay menu to empower biomarker
research and accelerate drug development.

SIMOA HD-X ANALYZER

Introducing the world’s most sensitive, fully automated immunoassay platform with multiplexing and custom assay capability

Key features include:

  • Ultra-sensitivity – Up to 1000x greater sensitivity than traditional immunoassays

  • Automation – Reproducibility and convenience of sample->answer workflow

  • Multiplexing - Measure up to 6 biomarkers in a single assay at fg/ml concentrations

  • Flexibility – Supports both high-throughput and rapid result workflows

  • Efficiency – Precise control of assay conditions allows for use of stored assay calibration values

  • Menu – Fully compatible with 80+ assays also available on HD-1 as well as customized homebrew assays

  • Regulatory Compliance – Enables 21CFR Part 11 compliance with streamlined run reports and user management

SIMOA HD-X ANALYZER

Unprecedented ultrasensitivity

 

Watch the video to learn more about the Simoa HD-1

READ MORE ABOUT SIMOA TECHNOLOGY

INTRODUCING THE SR-X ULTRA-SENSITIVE BIOMARKER DETECTION SYSTEM

The Quanterix SR-X™ Ultra-Sensitive Biomarker Detection System is the latest instrument powered by Simoa technology, offering researchers access to ultra-sensitive biomarker detection capabilities in a compact and affordable system. The SR-X is designed for multiplex detection of up to six analytes per well, with low volume requirements to increase productivity and throughput, while conserving your precious samples. A menu of over 70 Simoa assay kits will be available to measure critical biomarkers with substantially higher sensitivity than standard immunoassay methods, enabling detection of both normal and acute levels with high precision across a range of sample types.


The Quanterix SR-X also provides researchers with the additional flexibility to design assays to detect both protein and nucleic acid biomarkers direct from blood without the need for error-prone complex pre-analytical extraction and amplification steps. This unique capability enables measurement of ultra-sensitive nucleic acid levels, including miRNA, without PCR. 

QUANTERIX SR-X ULTRA-SENSITIVE BIOMARKER DETECTION SYSTEM

Key Features

  • Multiplex detection without compromising sensitivity or specificity

  • Simple 2-step or 3-step workflow  with minimal user intervention

  • Compact instrument with built-in touchscreen control and comprehensive data analysis tools

  • No daily or monthly user maintenance

  • Simple custom assay development for both protein and circulating nucleic acid detection

Powered by Medikonia Limited 2020